Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1931 1
1946 2
1948 1
1950 1
1966 2
1967 2
1970 3
1973 1
1984 3
1985 5
1986 3
1987 1
1993 1
1994 3
1995 1
1997 1
2003 1
2005 2
2006 3
2007 1
2008 2
2009 1
2010 4
2011 2
2012 2
2013 4
2014 7
2015 8
2016 5
2017 8
2018 9
2019 10
2020 8
2021 9
2022 8
2023 10
2024 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
CTLA-4: a moving target in immunotherapy.
Rowshanravan B, Halliday N, Sansom DM. Rowshanravan B, et al. Among authors: halliday n. Blood. 2018 Jan 4;131(1):58-67. doi: 10.1182/blood-2017-06-741033. Epub 2017 Nov 8. Blood. 2018. PMID: 29118008 Free PMC article. Review.
Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation.
Kennedy A, Waters E, Rowshanravan B, Hinze C, Williams C, Janman D, Fox TA, Booth C, Pesenacker AM, Halliday N, Soskic B, Kaur S, Qureshi OS, Morris EC, Ikemizu S, Paluch C, Huo J, Davis SJ, Boucrot E, Walker LSK, Sansom DM. Kennedy A, et al. Among authors: halliday n. Nat Immunol. 2022 Sep;23(9):1365-1378. doi: 10.1038/s41590-022-01289-w. Epub 2022 Aug 23. Nat Immunol. 2022. PMID: 35999394 Free PMC article.
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group.
Pape S, Snijders RJALM, Gevers TJG, Chazouilleres O, Dalekos GN, Hirschfield GM, Lenzi M, Trauner M, Manns MP, Vierling JM, Montano-Loza AJ, Lohse AW, Schramm C, Drenth JPH, Heneghan MA; International Autoimmune Hepatitis Group (IAIHG) collaborators(‡). Pape S, et al. J Hepatol. 2022 Apr;76(4):841-849. doi: 10.1016/j.jhep.2021.12.041. Epub 2022 Jan 20. J Hepatol. 2022. PMID: 35066089 Free article.
Liver transplantation: post-transplant management.
Halliday N, Westbrook RH. Halliday N, et al. Br J Hosp Med (Lond). 2017 May 2;78(5):278-285. doi: 10.12968/hmed.2017.78.5.278. Br J Hosp Med (Lond). 2017. PMID: 28489436 Free article. Review.
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
Colapietro F, Maisonneuve P, Lytvyak E, Beuers U, Verdonk RC, van der Meer AJ, van Hoek B, Kuiken SD, Brouwer JT, Muratori P, Aghemo A, Carella F, van den Berg AP, Zachou K, Dalekos GN, Di Zeo-Sánchez DE, Robles M, Andrade RJ, Montano-Loza AJ, van den Brand FF, Slooter CD, Macedo G, Liberal R, de Boer YS, Lleo A; Dutch AIH Study Group; International Autoimmune Hepatitis Group. Colapietro F, et al. J Hepatol. 2024 Jan;80(1):53-61. doi: 10.1016/j.jhep.2023.09.010. Epub 2023 Oct 5. J Hepatol. 2024. PMID: 37802188
UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis.
Abbas N, Culver EL, Thorburn D, Halliday N, Crothers H, Dyson JK, Phaw A, Aspinall R, Khakoo SI, Kallis Y, Smith B, Patanwala I, McCune A, Chimakurthi CR, Hegade V, Orrell M, Jones R, Mells G, Thain C, Thain RM, Jones D, Hirschfield G, Trivedi PJ. Abbas N, et al. Among authors: halliday n. Clin Gastroenterol Hepatol. 2023 Jun;21(6):1561-1570.e13. doi: 10.1016/j.cgh.2022.07.038. Epub 2022 Aug 9. Clin Gastroenterol Hepatol. 2023. PMID: 35961518 Free article.
Malignant hyperthermia.
Halliday NJ. Halliday NJ. J Craniofac Surg. 2003 Sep;14(5):800-2. doi: 10.1097/00001665-200309000-00039. J Craniofac Surg. 2003. PMID: 14501352
Measurement and interpretation of plasma ammonia.
Lee HJ, Halliday N, Bray GP. Lee HJ, et al. Among authors: halliday n. Br J Hosp Med (Lond). 2014 Mar;75(3):C40-3. doi: 10.12968/hmed.2014.75.sup3.c40. Br J Hosp Med (Lond). 2014. PMID: 24621668 Review. No abstract available.
Open challenges in the management of autoimmune hepatitis.
Gerussi A, Halliday N, Carbone M, Invernizzi P, Thorburn D. Gerussi A, et al. Among authors: halliday n. Minerva Gastroenterol (Torino). 2023 Mar;69(1):61-83. doi: 10.23736/S2724-5895.20.02805-6. Epub 2020 Dec 3. Minerva Gastroenterol (Torino). 2023. PMID: 33267568 Review.
Review article: experimental therapies in autoimmune hepatitis.
Halliday N, Dyson JK, Thorburn D, Lohse AW, Heneghan MA. Halliday N, et al. Aliment Pharmacol Ther. 2020 Oct;52(7):1134-1149. doi: 10.1111/apt.16035. Epub 2020 Aug 14. Aliment Pharmacol Ther. 2020. PMID: 32794592 Review.
128 results